The Victorian Heart Hospital and Victorian Heart Institute, operated by Monash Health in partnership with Monash University, have led a groundbreaking first-in-human trial of a gene-editing therapy that could permanently lower cholesterol and triglyceride levels in people with difficult-to-treat lipid disorders. …
Monash leads world-first trial of cholesterol-lowering gene-editing therapy
November 10, 2025 Latest NewsBioPharmaAustralian Biotech
Latest Video
New Stories
-
Australians open to AI in healthcare, but prefer doctors to be in control
November 13, 2025 - - Latest News -
Every Government agency to appoint a 'Chief AI Officer' under national plan
November 12, 2025 - - Latest News -
New Zealand accelerates medicines reform with major regulatory changes
November 12, 2025 - - Latest News -
FDA moves to lift long-standing hormone therapy warnings in major shift for women’s health
November 12, 2025 - - Latest News -
Optometry Australia and Alcon launch scholarship fund to support First Nations eye health leaders
November 12, 2025 - - Latest News -
Radiopharm Theranostics advances Phase 1 trial of 177Lu-RAD204 in PD-L1 positive cancers
November 12, 2025 - - Australian Biotech -
Arovella appoints former CSL Chief Scientific Officer Dr Andrew Nash to its Board
November 12, 2025 - - Australian Biotech